HER-2 I655V

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.

HER-2 I655V	Breast Cancer	HER-2 I655V	Breast Cancer	trastuzumab Sensitive: C3 – Early Trials trastuzumab Sensitive : C3	trastuzumab Sensitive: C3 – Early Trials trastuzumab Sensitive : C3
HER-2 I655V	Non Small Cell Lung Cancer	HER-2 I655V	Non Small Cell Lung Cancer	pyrotinib Sensitive: C3 – Early Trials pyrotinib Sensitive : C3	pyrotinib Sensitive: C3 – Early Trials pyrotinib Sensitive : C3
HER-2 I655V	HER2 Positive Breast Cancer	HER-2 I655V	HER2 Positive Breast Cancer	neratinib Sensitive: D – Preclinical neratinib Sensitive : D	neratinib Sensitive: D – Preclinical neratinib Sensitive : D

Associations